138 related articles for article (PubMed ID: 3051990)
1. Diltiazem and captopril alone or in combination for treatment of mild to moderate systemic hypertension.
Wolfson P; Abernethy D; DiPette DJ; Zusman R
Am J Cardiol; 1988 Oct; 62(11):103G-108G. PubMed ID: 3051990
[TBL] [Abstract][Full Text] [Related]
2. Comparison of hydrochlorothiazide and sustained-release diltiazem for mild-to-moderate systemic hypertension.
Frishman WH; Zawada ET; Smith LK; Sowers J; Swartz SL; Kirkendall W; Lunn J; McCarron D; Moser M; Schnaper H
Am J Cardiol; 1987 Mar; 59(6):615-23. PubMed ID: 3548301
[TBL] [Abstract][Full Text] [Related]
3. Antihypertensive efficacy and safe use of once-daily sustained-release diltiazem in the elderly: a comparison with captopril. The Dilcacomp Study Group.
Nicaise J; Neveux E; Blondin P
J Int Med Res; 1995; 23(4):244-53. PubMed ID: 7589767
[TBL] [Abstract][Full Text] [Related]
4. Diuretics versus calcium-channel blockers in systemic hypertension: a preliminary multicenter experience with hydrochlorothiazide and sustained-release diltiazem.
Frishman WH; Kirkendall W; Lunn J; McCarron D; Moser M; Schnaper H; Smith LK; Sowers J; Swartz S; Zawada E
Am J Cardiol; 1985 Dec; 56(16):92H-96H. PubMed ID: 3907323
[TBL] [Abstract][Full Text] [Related]
5. Antihypertensive efficacy of optimally titrated doses of once-daily sustained-release diltiazem: a placebo-controlled trial. DILPLACOMP Study Group.
Ollivier JP; Wajman A; Stalla-Bourdillon A
Cardiology; 1995; 86(6):481-7. PubMed ID: 7585759
[TBL] [Abstract][Full Text] [Related]
6. Sustained-release diltiazem: duration of antihypertensive effect.
Pool PE; Herron JM; Rosenblatt S; Reeves RL; Nappi JM; Staker LV; Dipette DJ; Evans RR
J Clin Pharmacol; 1989 Jun; 29(6):533-7. PubMed ID: 2666454
[TBL] [Abstract][Full Text] [Related]
7. Diltiazem as monotherapy for systemic hypertension: a multicenter, randomized, placebo-controlled trial.
Pool PE; Massie BM; Venkataraman K; Hirsch AT; Samant DR; Seagren SC; Gaw J; Salel AF; Tubau JF
Am J Cardiol; 1986 Feb; 57(4):212-7. PubMed ID: 3511660
[TBL] [Abstract][Full Text] [Related]
8. Comparative effects of diltiazem sustained-release and captopril on blood pressure control and plasma lipoproteins in primary hypertension: a randomized, double-blind, crossover study.
Lacourcière Y; Poirier L; Boucher S; Spenard J
J Hum Hypertens; 1990 Oct; 4(5):553-6. PubMed ID: 2283645
[TBL] [Abstract][Full Text] [Related]
9. Sustained-release diltiazem compared with atenolol monotherapy for mild to moderate systemic hypertension.
Weir MR; Josselson J; Giard MJ; Warren JB; Posner JN; Lam YW; Zaske DE; Saunders E
Am J Cardiol; 1987 Dec; 60(17):36I-41I. PubMed ID: 3318375
[TBL] [Abstract][Full Text] [Related]
10. Once daily compared with twice daily administration of slow-release diltiazem as monotherapy for hypertension.
Nikkilä M; Inkovaara J; Heikkinen J
Ann Med; 1991 Apr; 23(2):141-5. PubMed ID: 2069791
[TBL] [Abstract][Full Text] [Related]
11. Antihypertensive efficacy and tolerability of once-daily sustained-release diltiazem alone and in combination with ramipril in hypertension.
Tuteja R; Swarup D; Saxena GN; Bhandari S; Sharma P
J Assoc Physicians India; 1999 Oct; 47(10):962-5. PubMed ID: 10778687
[TBL] [Abstract][Full Text] [Related]
12. Comparative study on monotherapy with sustained-release diltiazem 300 mg and enalapril 20 mg in mild to moderate arterial hypertension.
Fermé I; Djian J; Tcherdakoff P
J Cardiovasc Pharmacol; 1990; 16 Suppl 1():S46-50. PubMed ID: 1706014
[TBL] [Abstract][Full Text] [Related]
13. A dose escalation trial comparing the combination of diltiazem SR and hydrochlorothiazide with the monotherapies in patients with essential hypertension.
Weir MR; Weber MA; Punzi HA; Serfer HM; Rosenblatt S; Cady WJ
J Hum Hypertens; 1992 Apr; 6(2):133-8. PubMed ID: 1597846
[TBL] [Abstract][Full Text] [Related]
14. Clinical experience with a once-daily, extended-release formulation of diltiazem in the treatment of hypertension.
Graney WF
Am J Med; 1992 Aug; 93(2A):56S-64S. PubMed ID: 1519637
[TBL] [Abstract][Full Text] [Related]
15. An assessment of diltiazem and hydrochlorothiazide in hypertension. Application of factorial trial design to a multicenter clinical trial of combination therapy.
Burris JF; Weir MR; Oparil S; Weber M; Cady WJ; Stewart WH
JAMA; 1990 Mar; 263(11):1507-12. PubMed ID: 2407872
[TBL] [Abstract][Full Text] [Related]
16. Antihypertensive effect of diltiazem in a slow-release formulation for mild to moderate essential hypertension.
Nikkilä MT; Inkovaara JA; Heikkinen JT; Olsson SO
Am J Cardiol; 1989 May; 63(17):1227-30. PubMed ID: 2711992
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of blood pressure response to the combination of enalapril (single dose) and diltiazem ER (four different doses) in systemic hypertension.
Applegate WB; Cohen JD; Wolfson P; Davis A; Green S
Am J Cardiol; 1996 Jul; 78(1):51-5. PubMed ID: 8712118
[TBL] [Abstract][Full Text] [Related]
18. Blood pressure control with diltiazem XR, a novel extended-release formulation of diltiazem HCl, in mature and elderly hypertensive patients.
Fiddes R; Heym H; Hilty W; Lewin AJ; Codispoti J; McNally C; Stokes A; Gilderman L
Clin Ther; 1994; 16(2):209-21. PubMed ID: 8062317
[TBL] [Abstract][Full Text] [Related]
19. A randomized, double-blind comparison of the antihypertensive efficacy and safety of once-daily losartan compared to twice-daily captopril in mild to moderate essential hypertension.
Roca-Cusachs A; Oigman W; Lepe L; Cifkova R; Karpov YA; Harron DW
Acta Cardiol; 1997; 52(6):495-506. PubMed ID: 9542575
[TBL] [Abstract][Full Text] [Related]
20. Atenolol plus nifedipine for mild to moderate systemic hypertension after fixed doses of either agent alone.
Daniels AR; Opie LH
Am J Cardiol; 1986 Apr; 57(11):965-70. PubMed ID: 3515899
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
